Literature DB >> 15331412

Resistance of CD1d-/- mice to ultraviolet-induced skin cancer is associated with increased apoptosis.

Yasuhiro Matsumura1, Angus M Moodycliffe, Dat X Nghiem, Stephen E Ullrich, Honnavara N Ananthaswamy.   

Abstract

Inhibition of p53-induced epidermal apoptosis, generation of p53 mutations, and suppressor T cells are the critical events responsible for the induction and development of UV-induced skin cancers. Recently, we demonstrated that CD1d knockout mice were resistant to UV-induced immunosuppression, prompting us to further address the role of CD1d in regulating UV carcinogenesis. We, therefore, investigated the response of wild-type (WT) and CD1d-/- mice to UV carcinogenesis. We found that although 100% of WT mice developed skin tumors after 45 weeks of UV irradiation, only 60% of CD1d-/- mice developed skin tumors. Surprisingly, keratinocytes and fibroblasts from CD1d-/- mice were more sensitive to UV-induced apoptosis and persisted longer than cells derived from WT mice. In addition, epidermis and dermis taken from chronically UV-irradiated CD1d-/- mice harbored significantly fewer p53 mutations than WT mice. Our findings identify an unexpected and novel function for CD1d as a critical molecule regulating UV carcinogenesis, by inhibiting apoptosis to prevent elimination of potentially malignant keratinocytes and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331412      PMCID: PMC1618602          DOI: 10.1016/S0002-9440(10)63350-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.

Authors:  S K Mendiratta; W D Martin; S Hong; A Boesteanu; S Joyce; L Van Kaer
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

Authors:  Y H Chen; N M Chiu; M Mandal; N Wang; C R Wang
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

3.  Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation.

Authors:  G Li; V Tron; V Ho
Journal:  J Invest Dermatol       Date:  1998-01       Impact factor: 8.551

4.  Molecular support for field cancerization in the head and neck.

Authors:  W M Lydiatt; P E Anderson; T Bazzana; M Casale; C J Hughes; A G Huvos; D D Lydiatt; S P Schantz
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

5.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

Review 6.  Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion.

Authors:  D E Brash; A Ziegler; A S Jonason; J A Simon; S Kunala; D J Leffell
Journal:  J Investig Dermatol Symp Proc       Date:  1996-04

7.  Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Authors:  R Honda; H Yasuda
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

8.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

9.  Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.

Authors:  M Exley; J Garcia; S P Balk; S Porcelli
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

10.  CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.

Authors:  L Brossay; M Chioda; N Burdin; Y Koezuka; G Casorati; P Dellabona; M Kronenberg
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  6 in total

1.  Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations.

Authors:  M A Adly; M A Adley; H A Assaf; M Hussein
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  RXRα ablation in epidermal keratinocytes enhances UVR-induced DNA damage, apoptosis, and proliferation of keratinocytes and melanocytes.

Authors:  Zhixing Wang; Daniel J Coleman; Gaurav Bajaj; Xiaobo Liang; Gitali Ganguli-Indra; Arup K Indra
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

3.  CD1d gene is a target for a novel amplicon at 1q22-23.1 in human hepatocellular carcinoma.

Authors:  Shi-Guang Zhang; Wen-Qin Song; Ying-Tang Gao; Bin Yang; Zhi Du
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

Review 4.  The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.

Authors:  Matthew J Bottomley; Jason Thomson; Catherine Harwood; Irene Leigh
Journal:  Int J Mol Sci       Date:  2019-04-24       Impact factor: 5.923

Review 5.  Roles and therapeutic potential of CD1d-Restricted NKT cells in inflammatory skin diseases.

Authors:  Sung Won Lee; Hyun Jung Park; Luc Van Kaer; Seokmann Hong
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

6.  UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d.

Authors:  Stephan Ryser; Marlène Schuppli; Beatrice Gauthier; Dianelys R Hernandez; Olivier Roye; Daniel Hohl; Bruce German; James A Holzwarth; Angus M Moodycliffe
Journal:  J Invest Dermatol       Date:  2013-07-18       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.